drugset / Trial / NCT00210717

A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia

NCT00210717

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effectiveness and safety over 1 year of treatment of intramuscular injections of paliperidone palmitate and long-acting risperidone in patients with schizophrenia.

Timeline

Start
2005-02
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject paliperidone palmitate Unknown 25 mg Intramuscular
Subject paliperidone palmitate Unknown 50 mg Intramuscular
Subject paliperidone palmitate Unknown 75 mg Intramuscular
Subject paliperidone palmitate Unknown 100 mg Intramuscular

Indications